Hospital Universitario Clínico San Carlos; Servicio de Oncologia
Madrid, Spain
University hospital in Madrid
Calle del Prof Martín Lagos, 28040 Madrid
861 Beds
About Hospital Universitario Clínico San Carlos; Servicio de Oncologia
The Hospital Clínico San Carlos is a hospital located at the Ciudad Universitaria neighborhood in Madrid, Spain, part of hospital network of the Servicio Madrileño de Salud. It is one of the healthcare institutions associated to the Complutense University of Madrid for the purpose of clinical internship.
There are 861 beds in Hospital Universitario Clínico San Carlos; Servicio de Oncologia.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
43
EMD Serono Research & Development Institute, Inc.
2
Clinical Trials at Hospital Universitario Clínico San Carlos; Servicio de Oncologia
During the past decade, Hospital Universitario Clínico San Carlos; Servicio de Oncologia conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 22 clinical trials were completed, i.e. on
average, 71% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
2009-06-25
2013-07-01
Completed
190
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
2012-02-02
2015-08-20
Completed
185
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hospital Universitario Clínico San Carlos; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" are
"Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Carcinoma, Hepatocellular" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Clínico San Carlos; Servicio de Oncologia
Most popular intervention types in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" are "Drug" (45 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (18 trials), "Carboplatin" (11 trials), "Paclitaxel" (10 trials), "Placebo" (10 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Clínico San Carlos; Servicio de Oncologia
The vast majority of trials in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia" are
40 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hospital Universitario Clínico San Carlos; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital Universitario Clínico San Carlos; Servicio de Oncologia".
undefined are not yet recruiting,
4 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in Hospital Universitario Clínico San Carlos; Servicio de Oncologia,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Clínico San Carlos; Servicio de Oncologia, 3 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 33 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".